Notably, the combination of FR+CTC, NSE, CEA, and CYFRA21-1 could significantly improve diagnostic efficacy in differentiating patients with lung cancer from those with benign lung disease (27). The gene discussed is CEACAM5; the disease is lung carcinoma.